Cargando…

Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant

Detalles Bibliográficos
Autores principales:	Tay, Matthew Zirui, Goh, Yun Shan, Fong, Siew-Wai, Chang, Zi Wei, Rouers, Angeline, Wong, Nathan, Torres-Ruesta, Anthony, Huang, Yuling, Selvam, Sooriya Kannan, Hor, Pei Xiang, Loh, Chiew Yee, Wang, Bei, Mohd Salleh, Siti Nazihah, Ngoh, Eve Zi Xian, Lee, Raphael Tze Chuen, Neo, Vanessa, Kam, Isaac Kai Jie, Poh, Xuan Ying, Rao, Suma, Chia, Po Ying, Ong, Sean W.X., Lee, Tau Hong, Lim, Clarissa, Teo, Jefanie, Maurer-Stroh, Sebastian, Wang, Cheng-I, Leo, Yee-Sin, Lin, Raymond Tzer Pin, Lye, David C., Young, Barnaby Edward, Ng, Lisa F.P., Renia, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988436/ https://www.ncbi.nlm.nih.gov/pubmed/37125085 http://dx.doi.org/10.1016/j.lanwpc.2023.100732

Ejemplares similares

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
por: Chang, Zi Wei, et al.
Publicado: (2023)

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
por: Wang, Bei, et al.
Publicado: (2021)

Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection
por: Tay, Matthew Zirui, et al.
Publicado: (2022)

Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
por: Wang, Bei, et al.
Publicado: (2021)

Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
por: Goh, Yun Shan, et al.
Publicado: (2023)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
por: Goh, Yun Shan, et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
por: Poh, Xuan Ying, et al.
Publicado: (2022)

B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain
por: Rouers, Angeline, et al.
Publicado: (2023)

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
por: Renia, Laurent, et al.
Publicado: (2022)

Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalisations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5 and XBB transmission
por: Wee, Liang En, et al.
Publicado: (2023)

Coding-Complete Genome Sequences of 40 SARS-CoV-2 Omicron XBB, XBB.1, and XBB.2 Sublineage Strains in Bangladesh
por: Habib, Mohammad Tanbir, et al.
Publicado: (2023)

Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
por: Ong, Sean Wei Xiang, et al.
Publicado: (2020)

Coding-complete genomes of XBB.1.16, XBB.2.3, FL.4 (alias of XBB.1.9.1.4), and XBB.3 of SARS-CoV-2 Omicron isolated from Bangladesh
por: Rahman, Saikt, et al.
Publicado: (2023)

BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer
por: Valanparambil, Rajesh M., et al.
Publicado: (2023)

Certain Subclasses of Analytic Functions with Complex Order
por: Selvam, A., et al.
Publicado: (2013)

Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study
por: Tan, Celine Y, et al.
Publicado: (2023)

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1
por: Pochtovyi, Andrei A., et al.
Publicado: (2023)

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2021)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
por: Kuramochi, Taichi, et al.
Publicado: (2022)

Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection
por: Lee, Pei Hua, et al.
Publicado: (2020)

Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 – the public health challenges
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2023)

Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
por: Goh, Yun Shan, et al.
Publicado: (2021)

XBB.1.5 an emerging threat: correspondence
por: Mohanty, Aroop, et al.
Publicado: (2023)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
por: Faraone, Julia N., et al.
Publicado: (2023)

Organ‐specific immune response in lethal SARS‐CoV‐2 infection by deep spatial phenotyping
por: Balachander, Akhila, et al.
Publicado: (2022)

Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19
por: Ng, Deborah H L, et al.
Publicado: (2020)

XBB.1.5 Kraken cracked: Gibbs energies of binding and biosynthesis of the XBB.1.5 variant of SARS-CoV-2
por: Popovic, Marko E.
Publicado: (2023)

Tumor-mediated microbiota alteration impairs synaptic tagging/capture in the hippocampal CA1 area via IL-1β production
por: Zhu, Ying, et al.
Publicado: (2023)

Monkeypox: disease epidemiology, host immunity and clinical interventions
por: Lum, Fok-Moon, et al.
Publicado: (2022)

What to know about Omicron XBB.1.5
por: Vogel, Lauren
Publicado: (2023)

BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer
por: Ehmsen, Sidse, et al.
Publicado: (2023)

Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients
por: Amrun, Siti Naqiah, et al.
Publicado: (2019)

Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

The absolute lymphocyte count accurately estimates CD4 counts in HIV-infected adults with virologic suppression and immune reconstitution
por: Young, Barnaby, et al.
Publicado: (2014)

Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 Cases in Maharashtra, India
por: Karyakarte, Rajesh P, et al.
Publicado: (2023)

Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial
por: Poh, Xuan Ying, et al.
Publicado: (2022)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4s8tni04v48jpnivi2lc4isjmi